bluecompanion eHealth project
  • About Us
    • Vision
    • Logo & Visual Identity
    • Team
    • Privacy
  • SCOTTY
  • GEROCOVID
    • Simposio Gerocovid 65° Congresso SIGG
    • Integration test
  • Events
    • ICFSR2019
    • Poster EUGMS 2019
    • Sprintt Meeting Treviso 2019
    • Sprintt Meeting Frankfurt 2018
    • SIGG 2020
    • SIGG 2019
    • Pictures
  • Bibliography
  • Contacts Us
Sign In
Hits: 8869
 Coronavirus SARS CoV 2 Gerocovid link
 
 
cartina2
 
 
 
 
 
 
FDA - Vaccines and Related Biological Products Advisory Committee - 10/12/2020 - YouTube

EMA - Public stakeholder meeting: development and authorisation of safe and effective COVID-19 vaccines in the EU | European Medicines Agency

 
 
GENERAL COVID-19 SELECTED PAPERS

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK 
Oxford–AstraZeneca COVID-19 vaccine efficacy
 Impact of non-pharmaceutical interventions (NPIs) to reduce COVID-19 mortality and healthcare demand
  16 march 2020 - Imperial College COVID-19 Response Team
 
 
"COVID-19 epidemic. 2 December 2020 national update” (pdf)

 

  • +44 20 30151247
  • +44 7576315434
  • info@bluecompanion.eu
© 2023 BlueCompanion BLUECOMPANION Ltd --------- 12a Neville Court, Abbey road NW89DD London, UK --------- BLUECOMPANION France 41 route de la Bernon, 78440 Jambville, France
  • About Us
    • Vision
    • Logo & Visual Identity
    • Team
    • Privacy
  • SCOTTY
  • GEROCOVID
    • Simposio Gerocovid 65° Congresso SIGG
    • Integration test
  • Events
    • ICFSR2019
    • Poster EUGMS 2019
    • Sprintt Meeting Treviso 2019
    • Sprintt Meeting Frankfurt 2018
    • SIGG 2020
    • SIGG 2019
    • Pictures
  • Bibliography
  • Contacts Us